Literature DB >> 22178568

The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.

Marong Fang1, Jing Wang, Xiaobing Zhang, Yu Geng, Zhiying Hu, John A Rudd, Shucai Ling, Wei Chen, Shu Han.   

Abstract

The role of miR-124 on the expression of β-site APP cleaving enzyme 1 (BACE1), an important cleavager of amyloid precursor protein that plays a pivotal role in the β-amyloid production, was studied in this paper using cellular models for Alzheimer' disease (AD) of cultured PC12 cell lines and primary cultured hippocampal neurons. The aim of the present study was to uncover novel potential miR-124 targets and shed light on its function in the cellular AD model. MiR-124 expression was steadily altered when its mimic and inhibitor were transfected in vitro. The results showed the expression of BACE1, one of the potential functional downstream targets of miR-124, was well correlated with cell death induced by Aβ neurotoxicity, and its expression level could be up- and down-regulated by suppression or over expression of miR-124 level respectively. These findings suggest that miR-124 may work as a basilic regulating factor to alleviate cell death in the process of AD by targeting BACE1, play an essential role in the control of BACE1 gene expression, and might be considered as a novel therapeutic target in treating AD.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178568     DOI: 10.1016/j.toxlet.2011.11.032

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  84 in total

1.  miR-186 is decreased in aged brain and suppresses BACE1 expression.

Authors:  Jaekwang Kim; Hyejin Yoon; Dah-Eun Chung; Jennifer L Brown; Krystal C Belmonte; Jungsu Kim
Journal:  J Neurochem       Date:  2016-03-30       Impact factor: 5.372

2.  Traceable microRNA-124 loaded nanoparticles as a new promising therapeutic tool for Parkinson's disease.

Authors:  Cláudia Saraiva; Lino Ferreira; Liliana Bernardino
Journal:  Neurogenesis (Austin)       Date:  2016-11-14

Review 3.  Body fluid biomarkers in Alzheimer's disease.

Authors:  Huan Lu; Xi-Chen Zhu; Teng Jiang; Jin-Tai Yu; Lan Tan
Journal:  Ann Transl Med       Date:  2015-04

4.  Ameliorative effects of astaxanthin on brain tissues of alzheimer's disease-like model: cross talk between neuronal-specific microRNA-124 and related pathways.

Authors:  Hala A Hafez; Maher A Kamel; Mohamed Y Osman; Hassan My Osman; Samar S Elblehi; Shimaa A Mahmoud
Journal:  Mol Cell Biochem       Date:  2021-02-11       Impact factor: 3.396

Review 5.  Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?

Authors:  Juan F Codocedo; Juvenal A Ríos; Juan A Godoy; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

Review 6.  Non-coding RNAs in Alzheimer's disease.

Authors:  Lin Tan; Jin-Tai Yu; Nan Hu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-10-07       Impact factor: 5.590

7.  Knockdown of miR-429 Attenuates Aβ-Induced Neuronal Damage by Targeting SOX2 and BCL2 in Mouse Cortical Neurons.

Authors:  Shengqi Fu; Jiewen Zhang; Shuling Zhang
Journal:  Neurochem Res       Date:  2018-09-27       Impact factor: 3.996

8.  MicroRNA-29b regulates ethanol-induced neuronal apoptosis in the developing cerebellum through SP1/RAX/PKR cascade.

Authors:  Yuanlin Qi; Mingfang Zhang; Hui Li; Jacqueline A Frank; Lu Dai; Huijuan Liu; Gang Chen
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

Review 9.  A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Sahil Tonk; Subodh Kumar; Murali Vijayan; Ramesh Kandimalla; Chandra Sekhar Kuruva; Arubala P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

10.  MicroRNA-135b has a neuroprotective role via targeting of β-site APP-cleaving enzyme 1.

Authors:  Yi Zhang; Hongxia Xing; Shuangxi Guo; Zhiyong Zheng; Haoliang Wang; Dawei Xu
Journal:  Exp Ther Med       Date:  2016-05-19       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.